Company Filing History:
Years Active: 2021
Title: Meghan Puopolo: Innovator in Antibody Development
Introduction
Meghan Puopolo is a prominent inventor based in Burlington, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. Her work focuses on innovative solutions that enhance diagnostic capabilities and treatment options.
Latest Patents
Meghan holds a patent for "Antibodies and assays for detection of CD37." This invention relates to antibodies that specifically bind to human CD37, which is crucial for developing diagnostic assays aimed at CD37-based therapies. Her patent represents a significant advancement in the field of immunology and diagnostics, showcasing her expertise and innovative spirit. She has 1 patent to her name.
Career Highlights
Meghan is currently employed at Debiopharm International S.A., where she continues to push the boundaries of scientific research and development. Her role at the company allows her to collaborate with other talented professionals in the field, contributing to groundbreaking projects that aim to improve patient outcomes.
Collaborations
Throughout her career, Meghan has worked alongside notable colleagues, including Jutta Deckert and Daniel J. Tavares. These collaborations have fostered a dynamic environment for innovation and have led to the development of impactful therapeutic solutions.
Conclusion
Meghan Puopolo is a dedicated inventor whose work in antibody development is paving the way for advancements in medical diagnostics and therapies. Her contributions to the field are invaluable, and her innovative spirit continues to inspire others in the biotechnology industry.